Literature DB >> 15502785

Quantitative assessment of aortic sclerosis using ultrasonic backscatter.

Doan T M Ngo1, Ronald D Wuttke, Stuart Turner, Thomas H Marwick, John D Horowitz.   

Abstract

BACKGROUND: The development of therapeutic interventions to prevent progressive valve damage is more likely to limit the progression of structural damage to the aortic valve with normal function (aortic sclerosis [ASC]) than clinically apparent aortic stenosis. Currently, the ability to appreciate the progression of ASC is compromised by the subjective and qualitative evaluation of sclerosis severity.
METHODS: We sought to reveal whether the intensity of ultrasonic backscatter could be used to quantify sclerosis severity in 26 patients with ASC and 23 healthy young adults. Images of the aortic valve were obtained in the parasternal long-axis view and saved in raw data format. Six square-shaped 11 x 11 pixel regions of interest were placed on the anterior and posterior leaflets, and calibrated backscatter values were obtained by subtracting the regions of interest in the blood pool from the averaged backscatter values obtained from the leaflets.
RESULTS: Mean ultrasonic backscatter values for sclerotic valves exceeded the results in normal valve tissue (16.3 +/- 4.4 dB vs 9.8 +/- 3.3 dB, P < .0001). Backscatter values were greater (22.0 +/- 3.5 dB) in a group of 6 patients with aortic stenosis. Within the sclerosis group, the magnitude of backscatter was directly correlated (P < .05) with a subjective sclerosis score, and with transvalvular pressure gradient. Mean reproducibility was 2.4 +/- 1.8 dB (SD) between observers, and 2.3 +/- 1.7 dB (SD) between examinations.
CONCLUSION: Measurement of backscatter from the valve leaflets of patients with ASC may be a feasible means of following the progression and treatment response of aortic sclerosis.

Entities:  

Mesh:

Year:  2004        PMID: 15502785     DOI: 10.1016/j.echo.2004.06.012

Source DB:  PubMed          Journal:  J Am Soc Echocardiogr        ISSN: 0894-7317            Impact factor:   5.251


  7 in total

Review 1.  Aortic sclerosis: not an innocent murmur but a marker of increased cardiovascular risk.

Authors:  A K Nightingale; J D Horowitz
Journal:  Heart       Date:  2005-03-29       Impact factor: 5.994

2.  Ramipril retards development of aortic valve stenosis in a rabbit model: mechanistic considerations.

Authors:  Doan Tm Ngo; Irene Stafford; Aaron L Sverdlov; Weier Qi; Ronald D Wuttke; Yuan Zhang; Darren J Kelly; Helen Weedon; Malcolm D Smith; Jennifer A Kennedy; John D Horowitz
Journal:  Br J Pharmacol       Date:  2011-02       Impact factor: 8.739

3.  Pathogenesis of aortic sclerosis: association with low BMI, tissue nitric oxide resistance, but not systemic inflammatory activation.

Authors:  Aaron L Sverdlov; Doan Tm Ngo; John D Horowitz
Journal:  Am J Cardiovasc Dis       Date:  2011-12-15

4.  Mitral and aortic valve sclerosis/calcification and carotid atherosclerosis: results from 1065 patients.

Authors:  Andrea Rossi; Pompilio Faggiano; Alexandra E Amado; Mariantonietta Cicoira; Stefano Bonapace; Lorenzo Franceschini; Frank L Dini; Stefano Ghio; Eustachio Agricola; Pier Luigi Temporelli; Corrado Vassanelli
Journal:  Heart Vessels       Date:  2013-11-07       Impact factor: 2.037

5.  The homeostatic chemokine CCL21 predicts mortality in aortic stenosis patients and modulates left ventricular remodeling.

Authors:  Alexandra Vanessa Finsen; Thor Ueland; Ivar Sjaastad; Trine Ranheim; Mohammed S Ahmed; Christen P Dahl; Erik T Askevold; Svend Aakhus; Cathrine Husberg; Arnt E Fiane; Martin Lipp; Lars Gullestad; Geir Christensen; Pål Aukrust; Arne Yndestad
Journal:  PLoS One       Date:  2014-11-14       Impact factor: 3.240

6.  Echocardiographic integrated backscatter for detecting progression and regression of aortic valve calcifications in rats.

Authors:  Bram Roosens; Gezim Bala; Kris Gillis; Isabel Remory; Steven Droogmans; Joan Somja; Eléonore Delvenne; Joeri De Nayer; Johan Schiettecatte; Philippe Delvenne; Patrizio Lancellotti; Guy Van Camp; Bernard Cosyns
Journal:  Cardiovasc Ultrasound       Date:  2013-01-26       Impact factor: 2.062

7.  Secreted Wnt modulators in symptomatic aortic stenosis.

Authors:  Erik Tandberg Askevold; Lars Gullestad; Svend Aakhus; Trine Ranheim; Theis Tønnessen; Ole G Solberg; Pål Aukrust; Thor Ueland
Journal:  J Am Heart Assoc       Date:  2012-12-19       Impact factor: 5.501

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.